Umiya Tubes Ltd

AGM details

• AGM held on September 30, 2026 via VC/OAVM.
• Meeting duration 3:00 PM to 3:09 PM.

Ordinary business and outcomes

• Adoption of Audited Financial Statements for FY 2025-26.
• Re-appointment of Viral Ranpura as Director on rotation.
• Appointment of M/s A. H. Mandaliya & Associates as Statutory Auditor for five years.
• Resolutions deemed passed on September 30, 2026.

Umiya Tubes Limited trading window closed from 1 October 2026 till 48 hours after the announcement of the unaudited financial results for the quarter ended 30 September 2026

AGM Details

• Date: 30 September 2026; Time: 3:00 PM IST; Mode: VC/OAVM.
• Deemed venue: registered office; remote e-voting window: 27–29 September 2026.
• Record/eligibility cut-off: 25 September 2026.

Key Resolutions

• Ordinary: adoption of audited financial statements for FY ended 31 March 2026.
• Ordinary: re-appointment of Viral Ranpura as Director by rotation.
• Ordinary: appointment of M/s A. H. Mandaliya & Associates as Statutory Auditor for five years.
• Special: alteration of Name Clause to enable change of company name, subject to ROC approval.
• Ordinary: increase in authorized share capital; amend MOA Clause V.

Auditor & Board Actions

• Proposed tenure: five-year term for Statutory Auditor commencing from this AGM.
• Proposed FY 2026-27 audit fee: Rs 4,00,000.
• Board authorized to file necessary forms with the Registrar of Companies.

Director Changes

• Viral Ranpura reappointed as Director by rotation.

Financial performance

• Revenue from operations: 1,275.83 Lakhs; total income: 1,298.85 Lakhs.
• PAT: 280.33 Lakhs; reversal from prior year's loss of 172.94 Lakhs.
• EBITDA: 282.23 Lakhs; cash costs contained.

Business transition & market context

• Shifted main object to tungsten-based products in Aug 2025.
• Revenue rise driven by tungsten line: 1,275.83 Lakhs in 2025-26.
• Global tungsten market: USD 5.43B in 2025; projected to USD 9.19B by 2034.
• Asia-Pacific held ~71.6% of tungsten market in 2025.

Capital structure & fundraising

• Authorized share capital raised to Rs 30 crore.
• Preferential issues: 29.50 lakh equity shares and 75.12 lakh warrants.
• Outstanding equity shares: 12,956,667 at year-end (₹1,295.67 lakh).
• Funds raised: Rs 14.27 crore via preferential equity and warrants; used for capex and working capital.

Governance & audit

• Auditors: M/s P. Singhvi & Associates; AH Mandaliya & Associates proposed for 5-year term (subject to AGM).
• Audit committee held 5 meetings in 2025-26; chaired by independent director.
• Secretarial audit: Dipika Soni & Associates; CSR policy disclosed on company site.

Taxation & regulatory

• Income tax demand of Rs 18.11 lakh for AY 2018-19; appeal filed.
• GST demands: Rs 6.33 lakh (FY 2020-21) and Rs 6.14 lakh (FY 2022-23); appeals filed.

Outlook & risks

• Management envisions growth from renewables and tungsten lines; macro/policy risks acknowledged.
• Robust risk management framework; emphasis on credit policy and internal controls.

Key Decisions

• Revision of 13th AGM notice with proposed resolutions for Sept 30, 2026, 3:00 PM via VC/OAVM.
• Appointed M/s Malay Desai & Associates as Scrutinizer for remote e-voting and AGM voting.
• Appointed M/s A. H. Mandaliya & Associates as Statutory Auditors for five-year term, subject to member approval.
• Profile of M/s A. H. Mandaliya & Associates attached.

Financial results

• Unaudited standalone Q1 FY2026 results for quarter ended 30 June 2026 approved; limited review by statutory auditor.
• Results declared with a 4-day delay due to unavailability of directors.

Registered office change

• Registered office shifted to 415 Shivam Trade Center, Ambli Junction, Ahmedabad 380058, effective 20 Aug 2026.
• New premises fully operational by 24 Aug 2026.

Meeting Details

• Board meeting on Aug 19, 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited financial results for quarter ended 30 June 2026.

Other Notes

• Trading window closed from 1 July 2026 until 48 hours after announcement of the board outcome.